Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System

Amit A Somani1, Kirstin Thelen2, Songmao Zheng1

  • 1Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, FL, USA.

Insights

Oral drug absorption in neonates reaches adult levels within one week after birth. This drug-independent maturation function, identified for paracetamol, applies to Biopharmaceutics Classification System (BCS) class I and II drugs.

Area of Science:

  • Pharmacokinetics
  • Paediatric pharmacotherapy
  • Drug absorption

Background:

  • Oral drug absorption rates vary in early childhood, with unclear clinical implications, especially for preterm neonates.
  • Understanding these changes is crucial for optimizing paediatric drug therapy.

Purpose of the Study:

  • To evaluate oral drug absorption changes after birth for Biopharmaceutics Classification System (BCS) class I and II compounds.
  • To inform paediatric pharmacotherapy by understanding drug absorption maturation in neonates.

Main Methods:

  • Population pharmacokinetic analysis using NONMEM® 7.2.
  • Comparative analysis of BCS class I (paracetamol, theophylline) and class II (indomethacin, ibuprofen) compounds.
  • Development of an age-dependent maturation function for oral drug absorption.

Main Results:

  • Oral drug absorption rate reaches adult levels within approximately one week post-birth.
  • A maturation function developed for paracetamol was applicable to theophylline and indomethacin, considering formulation-based solubility.
  • Excipient influence on solubility and bioavailability was confirmed for ibuprofen.

Conclusions:

  • Postnatal oral drug absorption changes are drug-independent.
  • The identified maturation function for paracetamol is likely generalizable to other BCS class I and II drugs.
  • This aids in characterizing drug absorption in both preterm and term neonates.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
750
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
804
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
482
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
337
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.6K